Partner/Networks
Prolytic GmbH, Frankfurt
PRIMACYT has started a cooperation with Frankfurt based Prolytic GmbH to analyze the metabolism of chemical substances in cell cultures. Thereby, experiments performed in PRIMACYT's hepatocytes cultures are combined with a highly efficient and sensitive chemical analysis of compounds. Thus, animal experiments will be reduced.
Downloads
Press release Prolytic PRIMACYT
Cooperation scheme
www.prolytic.de
Bionas GmbH, Rostock
As a first user, Bionas has combined its own sensor chip technology with the hepatocyte culture systems developed by PRIMACYT. Bionas uses this combination of technologies to analyze chemical compounds. Bionas and PRIMACYT work closely together to develop new cell based assays for the analysis of hepatotoxic effects caused by chemicals.
Downloads
Thedinga et al. 2007
www.bionas.de
University of Pittsburgh, Department of Pathology
A very close cooperation exists between the University of Pittsburgh and PRIMACYT. Together with researchers of the Department of Pathology PRIMACYT is working on the development of a human hepatocyte culture model that should allow a better prediction of drug action.
University of Pittsburgh, Dept of Pathology
Cooperation CYTOFAB
PRIMACYT is one of nine partners participating in the EU funded 7th framework programme. Our aim in the next three years beginning in May 2010 is the development of a self-learning modular manufacturing platform for flexible, patient-specific cell production. The project was initiated and is coordinated by Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) in Stuttgart.
www.cytofab-project.eu
Private Clinic Dr. Brunkow, Clinic for plastic and esthetic surgery
The 7th Amendment to the Cosmetic Directive (2003/15/EC) provides an animal testing ban on ingredients and a marketing ban on cosmetics that contain ingredients tested on animals.
The European Community regulation on chemicals and their safe use, REACH, (EC 1907/2006) requests the analysis and the estimation of the potential toxicity a chemical may have to human health and the environment. Under this regulation, about 30,000 chemicals have to be tested. Chemicals that are produced in small amounts are to be tested with animal free experiments.
Therefore, PRIMACYT has started a close collaboration with a number of clinics for plastic surgery to develop two- and three-dimensional human skin models for the testing of chemicals and cosmetics. One of our first partners to start this project is the Private Clinic Brunkow in Rostock.
www.privatklinik-brunkow.de
Prolytic GmbH, Frankfurt
PRIMACYT has started a cooperation with Frankfurt based Prolytic GmbH to analyze the metabolism of chemical substances in cell cultures. Thereby, experiments performed in PRIMACYT's hepatocytes cultures are combined with a highly efficient and sensitive chemical analysis of compounds. Thus, animal experiments will be reduced.
Downloads
Press release Prolytic PRIMACYT
Cooperation scheme
www.prolytic.de
Bionas GmbH, Rostock
As a first user, Bionas has combined its own sensor chip technology with the hepatocyte culture systems developed by PRIMACYT. Bionas uses this combination of technologies to analyze chemical compounds. Bionas and PRIMACYT work closely together to develop new cell based assays for the analysis of hepatotoxic effects caused by chemicals.
Downloads
Thedinga et al. 2007
www.bionas.de
University of Pittsburgh, Department of Pathology
A very close cooperation exists between the University of Pittsburgh and PRIMACYT. Together with researchers of the Department of Pathology PRIMACYT is working on the development of a human hepatocyte culture model that should allow a better prediction of drug action.
University of Pittsburgh, Dept of Pathology
Cooperation CYTOFAB
PRIMACYT is one of nine partners participating in the EU funded 7th framework programme. Our aim in the next three years beginning in May 2010 is the development of a self-learning modular manufacturing platform for flexible, patient-specific cell production. The project was initiated and is coordinated by Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) in Stuttgart.
www.cytofab-project.eu
Private Clinic Dr. Brunkow, Clinic for plastic and esthetic surgery
The 7th Amendment to the Cosmetic Directive (2003/15/EC) provides an animal testing ban on ingredients and a marketing ban on cosmetics that contain ingredients tested on animals.
The European Community regulation on chemicals and their safe use, REACH, (EC 1907/2006) requests the analysis and the estimation of the potential toxicity a chemical may have to human health and the environment. Under this regulation, about 30,000 chemicals have to be tested. Chemicals that are produced in small amounts are to be tested with animal free experiments.
Therefore, PRIMACYT has started a close collaboration with a number of clinics for plastic surgery to develop two- and three-dimensional human skin models for the testing of chemicals and cosmetics. One of our first partners to start this project is the Private Clinic Brunkow in Rostock.
www.privatklinik-brunkow.de
